Código de Ética
Multiple, redundant or simultaneous publication.
In general, an author should not publish manuscripts describing essentially the same research in more than one primary publishing journal. Submitting the same manuscript to more than one journal simultaneously constitutes unethical behavior and is unacceptable.
If in the submitted article there are similarities detected in the anti-plagiarism software (Urkund) that exceed 5% and do not include the proper bibliographical references, they will not be accepted.
In general, an author should not submit for consideration by another journal a work that has been previously published, except in abstract form or as part of a published academic conference or thesis or as an electronic preprint.
Publication of some types of articles (e.g., clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals in question must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication.
The authorship of the document.
Authorship should be limited to those who have contributed significantly to the conception, design, execution, or interpretation of the reported study. All those who have made substantial contributions should be listed as co-authors.
If there are other people who have participated in certain substantive aspects of the work, they must be recognized in the acknowledgments section.
The corresponding author must ensure that the document includes all appropriate co-authors and that no inappropriate co-authors are included, and that all co-authors have seen and approved the final version of the document and have accepted its submission for publication.
Authors are expected to carefully consider the list and order of authors before submitting their manuscript and to provide the final list of authors at the time of original submission. Only in exceptional circumstances will the Editor consider (at his discretion) the addition, deletion or rearrangement of authors after the manuscript has been submitted and the author must clearly mark any such request to the Editor. All authors must agree to any such addition, deletion, or rearrangement.
The authors assume collective responsibility for the work. Each author is responsible for ensuring that questions regarding the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Hazards and human/animal subjects.
If the work includes chemicals, procedures, or equipment that present unusual risks inherent to their use, the author must clearly identify them in the manuscript.
If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the appropriate institutional committees. Authors should include a statement in the manuscript that informed consent for experimentation with human subjects was obtained; and the use of ancestral knowledge and practices about plants and animals. The privacy rights of human subjects must always be respected.
Appropriate consents, permissions and releases must be obtained when an author wishes to include case details or other personal information or images of any individual in a publication. The author must retain written consents and must provide the journal, upon request, with copies of the consents or evidence that such consents have been obtained.
Conflicts of interest.
Todos los autores deben revelar en su manuscrito cualquier relación financiera y personal con otras personas u organizaciones que podrían considerarse que influyen (sesgan) de manera inapropiada en su trabajo.
Se deben divulgar todas las fuentes de apoyo financiero para realizar la investigación y/o preparar el artículo, así como el papel del patrocinador, si lo hubiere, en el diseño del estudio; en la recopilación, análisis e interpretación de datos; por escrito el informe; y en la decisión de enviar el artículo para su publicación. Si la(s) fuente(s) de financiación no tienen tal participación, entonces esto debe declararse.
Ejemplos de posibles conflictos de intereses que deben divulgarse incluyen empleo, consultorías, propiedad de acciones, honorarios, testimonios de expertos pagados, solicitudes/registros de patentes y subvenciones u otros fondos. Los posibles conflictos de intereses deben revelarse lo antes posible.
Referencias.
Declaración de Helsinki de la Asociación Médica Mundial (AMM) para la investigación médica con seres humanos https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research
Investigación con animales: Directrices para informar experimentos in vivo (ARRIVE) https://www. ncars.org.uk/arrive-guidelines
Ley de animales (procedimientos científicos) del Reino Unido de 1986 https://www.gov.uk/government/uploads/ svstem/uploads/attachment data/file/aoS^Qa/ConsolidatedASPAil an20ia.pdf
Directiva de la UE 2010/63/UE sobre experimentos con animales http://ec.europa. ue/medio ambiente/productos químicos/animales de laboratorio/legislación en.htm
Política del Servicio de Salud Pública de los Estados Unidos sobre el cuidado y uso humanitario de animales de laboratorio https://grants.nih.gov/gra nts/olaw/references/phspol icvlabanimals.pdf
Ministerio del Ambiente Ecuador (MAE) Ley para la conservación y uso sustentable de la biodiversidad. Código Orgánico Ambiental. https://www.ambiente.gob.ec/wp-content/uploads/downloads/2018/01/CODIGO_ORGANICO_AMBIENTE.pdf
